55 related articles for article (PubMed ID: 11256225)
21. Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke.
Anderson CD; Bergman DL; Bernstein RA
Neurocrit Care; 2005; 3(1):54-6. PubMed ID: 16159096
[TBL] [Abstract][Full Text] [Related]
22. [Can systemic changes in the blood coagulation system be detected in low-dose local thrombolysis with r-tPA?].
Weichenhain B; Stiegler H; Spengel F; Standl E; Woitinas F; Roth R; Schulz K; Mehnert H
Vasa Suppl; 1991; 32():314-7. PubMed ID: 1771523
[No Abstract] [Full Text] [Related]
23. [Thrombolytic therapy in apoplexy].
Vorstrup S; Olesen J; Husted SE
Ugeskr Laeger; 1999 Mar; 161(11):1570. PubMed ID: 10202437
[No Abstract] [Full Text] [Related]
24. An update on thrombolytic therapy for acute stroke.
Schellinger PD; Kaste M; Hacke W
Curr Opin Neurol; 2004 Feb; 17(1):69-77. PubMed ID: 15090880
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acute ischemic stroke: selecting the right treatment for the right patient.
Adams HP
Eur Neurol; 2001; 45(2):61-6. PubMed ID: 11244267
[TBL] [Abstract][Full Text] [Related]
26. [Is the attenuation of thromboembolic vascular occlusions a criterion for the prognosis of thrombolysis?].
Kirchhof K; Mecke C; Lichy C; Sartor K
Rofo; 2003 Aug; 175(8):1130-7. PubMed ID: 12886484
[TBL] [Abstract][Full Text] [Related]
27. Treating stroke.
Verbeek R
CMAJ; 2000 May; 162(9):1273-4. PubMed ID: 10813005
[No Abstract] [Full Text] [Related]
28. [Superselective local intraarterial fibrinolysis].
Ezura M; Takahashi A
No To Shinkei; 2000 Oct; 52(10):865-70. PubMed ID: 11070918
[No Abstract] [Full Text] [Related]
29. [Treatment of acute stroke with systemic thrombolysis--benefit or risk?].
Lyrer P; Fluri F
Praxis (Bern 1994); 2001 Feb; 90(7):253-6. PubMed ID: 11256225
[No Abstract] [Full Text] [Related]
30. [Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge].
Murray V; Norrving B; Terént A; Wester P
Lakartidningen; 2004 Feb; 101(8):662-8, 670-3. PubMed ID: 15024939
[TBL] [Abstract][Full Text] [Related]
31. Tissue plasminogen activator does not benefit most eligible patients with stroke.
Lansberg MG; Schwartz NE
Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
[No Abstract] [Full Text] [Related]
32. Systemic thrombolysis in clinical practice: what have we learned after the Safe Implementation of Thrombolysis in Stroke Monitoring Study?
Wahlgren N
Cerebrovasc Dis; 2009; 27 Suppl 1():168-76. PubMed ID: 19342848
[TBL] [Abstract][Full Text] [Related]
33. Cardiac papillary fibroelastoma: source of cerebral embolism treated with intravenous thrombolysis.
Matijević V; Poljaković Z; Ilić I; Cikeš I; Habek M
J Stroke Cerebrovasc Dis; 2011; 20(5):485-7. PubMed ID: 20692856
[TBL] [Abstract][Full Text] [Related]
34. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
